1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents
2.5. Market Size Estimation
2.6. Assumption for the Study
2.7. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Biopharmaceutical Logistics Industry Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Company Market Share Analysis, 2018
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
5. Global Biopharmaceutical Logistics Market Overview
5.1. Market Size & Forecast by Value, 2015-2025
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Logistic Type
5.2.1.1. Cold Chain Logistics
5.2.1.2. Non-cold Chain Logistics
5.2.2. By Product Type
5.2.2.1. Generic Drugs
5.2.2.2. Branded Drugs
5.2.3. By Mode of Transportation
5.2.3.1. Air Shipping
5.2.3.2. Sea Shipping
5.2.3.3. Road Shipping
5.2.3.4. Rail Shipping
5.2.4. By Retail Format
5.2.4.1. Specialty stores
5.2.4.2. Hyper markets
5.2.4.3. Departmental Stores
5.2.4.4. Other Retailers
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East & Africa
6. North America Biopharmaceutical Logistics Market
6.1. Market Size & Forecast by Value, 2015-2025
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Logistic Type
6.2.2. By Product Type
6.2.3. By Mode of Transportation
6.2.4. By Retail Format
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Europe Biopharmaceutical Logistics Market
7.1. Market Size & Forecast by Value, 2015-2025
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Logistic Type
7.2.2. By Product Type
7.2.3. By Mode of Transportation
7.2.4. By Retail Format
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. Rest of Europe
8. Asia Pacific Biopharmaceutical Logistics Market
8.1. Market Size & Forecast by Value, 2015-2025
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Logistic Type
8.2.2. By Product Type
8.2.3. By Mode of Transportation
8.2.4. By Retail Format
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. Rest of Asia Pacific
9. Latin America Biopharmaceutical Logistics Market
9.1. Market Size & Forecast by Value, 2015-2025
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Logistic Type
9.2.2. By Product Type
9.2.3. By Mode of Transportation
9.2.4. By Retail Format
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
10.Middle East & Africa Biopharmaceutical Logistics Market
10.1. Market Size & Forecast by Value, 2015-2025
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Logistic Type
10.2.2. By Product Type
10.2.3. By Mode of Transportation
10.2.4. By Retail Format
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
11.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
11.1. Deutsche Post DHL
11.2. Kuehne + Nagel
11.3. DB Schenker FedEx
11.4. AmerisourceBergen
11.5. UPS (Marken)
11.6. XPO Logistics
11.7. Panalpina
11.8. VersaCold
11.9. Agility
11.10. DSV
11.11. Nippon Express
11.12. GEODIS
11.13. Sinotrans
11.14. Kerry Logistics
11.15. SF Express
11.16. Other Prominent Players
-Financial details in case of unlisted companies will be available as per data availability
-The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable